Clavulanate (potassium)

• UNSPSC Description:

  Clavulanate potassium is a potent β-lactamase inhibitor and acts as an antibiotic[1][2].

• Target Antigen:

  Antibiotic; Bacterial; Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/clavulanate-potassium.html

• Purity:

  95.23

• Solubility:

  10 mM in H2O

• Smiles:

  O=C([C@@H](/C(O[C@]1([H])C2)=C/CO)N1C2=O)O[K]

• Molecular Weight:

  237.25

• References & Citations:

  [1]Reading C, et al. Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May; 11(5): 852–857.|[2]Stokes DH, et al. Bactericidal effects of amoxycillin/clavulanic acid against intracellular Legionella pneumophila in tissue culture studies. J Antimicrob Chemother. 1989 Apr;23(4):547-56.Biomed Res Int. 2018 Jul 2;2018:3579832. |bioRxiv. 2024 May 10.|Nat Commun. 2022 Mar 2;13(1):1116.|Eur J Pharmacol. 2024 Sep 28:177017.|Genomics. 2022: 110527.|Int J Mol Sci. 2023 Oct 27, 24(21), 15657.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  Launched

• CAS Number:

  61177-45-5